Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.33 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2533168 | 0.85 | APP (0.42) | APPMAPT | |
| SCHEMBL28693933 | 0.83 | SRD5A2 (0.53) | TSHRHTT | |
| SCHEMBL719360 | 0.82 | LMNA (0.57) | LMNACYP2A6KCNH2GRM5MAOA | |
| SCHEMBL20015814 | 0.82 | LMNA (0.57) | LMNACYP2A6KCNH2GRM5MAOA | |
| Charcoal, Activated SCHEMBL31286310 | 0.79 | KCNH2 (0.54) | LMNACYP2A6KCNH2GRM5MAOA | |
| SCHEMBL3433279 | 0.78 | LMNA (0.44) | LMNACYP2A6KCNH2GRM5MAOA | |
| SCHEMBL30486018 | 0.77 | CYP1A1 (0.44) | KCNH2GRM5APPMAPT | |
| SCHEMBL4461464 | 0.76 | KCNH2 (0.47) | LMNACYP2A6KCNH2GRM5MAOA | |
| SCHEMBL20138872 | 0.74 | CYP2A6 (0.47) | LMNACYP2A6MAOAMAOBACACB | |
| SCHEMBL2879214 | 0.74 | LMNA (0.47) | LMNACYP2A6KCNH2GRM5MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116162046-A | Alkynyl sulfone derivative and preparation method and application thereof | 云南民族大学 | 2023-05-26 | — | — | CN | claimed |
| CN-107986969-B | Dodecahydron as benzodiindenophenanthrene derivative and synthesis method thereof | 安徽师范大学 | 2020-06-19 | — | — | CN | claimed |
| CN-116162046-B | Alkynyl sulfone derivative and preparation method and application thereof | 云南民族大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-120118016-A | 1, 1-Di (indolyl) olefin compound and preparation method and application thereof | 华南理工大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-118515668-A | Condensed ring indolizine compound and synthetic method and application thereof | 安徽师范大学 | 2024-08-20 | — | — | CN | disclosed |
| CN-115819301-B | Method for preparing alkynyl sulfur (selenium) ether by coupling zinc-promoted disulfide (selenium) ether with alkynyl bromine | 湖南大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-115197046-B | Halogenation method of unsaturated hydrocarbon | 华南理工大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-113800998-B | Preparation method of (2-bromoethynyl) benzene compound | 浙江师范大学 | 2023-08-25 | — | — | CN | disclosed |
| CN-114591198-B | Preparation method of cyanoalkyne compound | 江苏科技大学 | 2023-07-21 | — | — | CN | disclosed |
| CN-114989063-B | Synthesis method of beta-halogenated pyrrole compound | 华南理工大学 | 2023-07-18 | — | — | CN | disclosed |
| CN-116162046-A | Alkynyl sulfone derivative and preparation method and application thereof | 云南民族大学 | 2023-05-26 | — | — | CN | disclosed |
| US-20100216814-A1 | PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES | MEDIVATION TECHNOLOGIES, INC. | 2010-08-26 | — | — | US | disclosed |
| US-20100152163-A1 | AZEPINO[4,5-B]INDOLES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. | 2010-06-17 | — | — | US | disclosed |
| WO-2010051501-A1 | PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES | MEDIVATION TECHNOLOGIES, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010051503-A1 | AZEPINO [4, 5-B] INDOLES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010051501-A1 | PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES | MEDIVATION TECHNOLOGIES, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| US-20100099667-A1 | BRIDGED HETEROCYCLIC COMPOUNDS AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. | 2010-04-22 | — | — | US | disclosed |
| US-20090270412-A1 | PYRIDO[3,4-B]INDOLES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. | 2009-10-29 | — | — | US | disclosed |
| WO-2009120717-A2 | PYRIDO [3, 4-B] INDOLES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. (US) | 2009-10-01 | — | — | WO | disclosed |
| WO-2009120720-A1 | BRIDGED HETEROCYCLIC COMPOUNDS AND METHODS OF USE | MEDIVATION TECHNOLOGIES,INC. (US) | 2009-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270412-A1 | PYRIDO[3,4-B]INDOLES AND METHODS OF USE | HTR3B, HTR4, HTR2C | LMNA 4568/4885CYP2A6 949/4885KCNH2 1610/4885 |
| US-20100216814-A1 | PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES | HTR3B, HTR3D, HTR3A | LMNA 3212/4885CYP2A6 648/4885KCNH2 988/4885 |
| US-20100152163-A1 | AZEPINO[4,5-B]INDOLES AND METHODS OF USE | HTR2C, HTR5A, HTR4 | LMNA 4792/4885CYP2A6 469/4885KCNH2 579/4885 |
| US-20100099667-A1 | BRIDGED HETEROCYCLIC COMPOUNDS AND METHODS OF USE | HRH4, HNMT, HTR2C | LMNA 4766/4885CYP2A6 1518/4885KCNH2 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.